Arena Pharmaceuticals, Inc. Finite-Lived Intangible Assets, Net
Arena Pharmaceuticals, Inc. had Finite-Lived Intangible Assets, Net of $1.55 million as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2017-11-08
- 2017-09-30: Finite-Lived Intangible Assets, Net $1.55M.
- 2017-06-30: Finite-Lived Intangible Assets, Net $1.88M.
- 2017-03-31: Finite-Lived Intangible Assets, Net $2.10M.
- 2016-12-31: Finite-Lived Intangible Assets, Net $2.36M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2017-09-30 | $1.55M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.88M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.10M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.36M 10-Q · filed 2017-11-08 |
| 2016-09-30 | $7.52M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $7.62M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $7.95M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $7.78M 10-K · filed 2017-03-15 |
| 2015-09-30 | $8.12M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $8.66M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $8.50M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $8.48M 10-K · filed 2016-02-29 |
| 2013-12-31 | $10.18M 10-K · filed 2015-03-02 |
| 2012-12-31 | $10.61M 10-K · filed 2014-03-03 |
| 2011-12-31 | $11.03M 10-K · filed 2013-03-01 |